The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.

被引：0

作者：

De Simone, P. ^{[1
]}

Kaiser, G. M. ^{[1
]}

De Carlis, L. ^{[1
]}

Metselaar, H. J. ^{[1
]}

Duvoux, C. ^{[1
]}

Nevens, F. ^{[1
]}

Fischer, L. ^{[1
]}

Fung, J. ^{[1
]}

Dong, G. ^{[1
]}

Rauer, B. ^{[1
]}

Junge, G. ^{[1
]}

Saliba, F. ^{[1
]}

机构：

[1] H2304E1 Study Grp, Pisa, Italy

来源：

LIVER TRANSPLANTATION | 2014年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

O-10

引用

页码：S106 / S106

页数：1

共 50 条

[1] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 710 - 710
[2] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
[3] EVEROLIMUS WITH REDUCED TACROLIMUS PRESERVES LONG-TERM RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: 36 AND 48 MONTHS RESULTS FROM THE H2304E1 STUDY
Saliba, F.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Lopez, P.
Dong, G.
Di Giambattista, F.
Duvoux, C.
TRANSPLANT INTERNATIONAL, 2016, 29 : 7 - 7
[4] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
Fung, J.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
Nevens, F.
Duvoux, C.
De Simone, P.
Fischer, L.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 180 - 180
[5] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
Fung, J.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
Nevens, F.
Duvoux, C.
De Simone, P.
Fischer, L.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 180 - 180
[6] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
Saliba, Faouzi
Kaiser, Gernot M.
De Carlis, Luciano
Metselaar, Herold J.
De Simone, Paolo
Duvoux, Christophe
Nevens, Frederik
Fischer, Lutz
Fung, John J.
Dong, Gaohong
Rauer, Barbara
Junge, Guido
HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
[7] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
Saliba, F.
Duvoux, C.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Di Giambattista, F.
TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18
[8] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
Schlitt, H. J.
Nashan, B.
Schemmer, P.
Pascher, A.
Klein, C. G.
Neumann, U.
Kroeger, I.
Wimmer, P.
Braun, F.
TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
[9] EVALUATING THE EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS: H2307 STUDY DESIGN
Sips, C.
Suh, K. S.
Joh, J. W.
Yoshizumi, T.
Lee, W. C.
Genyk, Y.
Martzloff, E. -D.
Wang, Z.
Lopez, P.
Grant, D.
JOURNAL OF HEPATOLOGY, 2015, 62 : S858 - S859
[10] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
De Simone, P.
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Fischer, L.
Foltys, D.
Koneru, B.
Wang, Y.
Hexham, J. M.
Junge, G.
Fung, J.
LIVER TRANSPLANTATION, 2012, 18 : S85 - S86

← 1 2 3 4 5 →